NCT00320619View on ClinicalTrials.gov

Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery

NACompletedINTERVENTIONAL

Enrollment

182

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

ScoliosisKyphosisLordosisSpondylitisSpinal Stenosis

Interventions

DRUG

Epsilon-Aminocaproic Acid (EACA)

Participants will receive EACA intravenously during surgery and for 8 hours following surgery in the intensive care unit (ICU).

DRUG

Placebo

Participants will receive placebo intravenously during surgery and for 8 hours following surgery in the intensive care unit (ICU).

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00320619 - Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery | Biotech Hunter | Biotech Hunter